SCI
12September
DifferentialImmune-RelatedMicroenvironmentDeterminesPD-1/PD-L1BlockadeEfficacyinAdvancedNon-SmallCellLungCancerPatients
（IF:JThoracOncol.,15.）
ShirasawaM,YoshidaT,ShimodaY,TakayanagiD,ShiraishiK,KuboT,MitaniS,MatsumotoY,MasudaK,ShinnoY,OkumaY,GotoY,HorinouchiH,IchikawaH,KohnoT,YamamotoN,MatsumotoS,GotoK,WatanabeSI,OheY,MotoiN.DifferentialImmune-RelatedMicroenvironmentDeterminesPD-1/PD-L1BlockadeEfficacyinAdvancedNon-SmallCellLungCancerPatients.JThoracOncol.Aug19:S-(21)-X.
Correspondingauthor:TatsuyaYoshida,MD,Ph.D.DepartmentofThoracicOncology,NationalCancerCenterHospital,5‐1‐1Tsukiji,Chuo‐ku,Tokyo,‐,Japan.Tel:+,Fax:+
Background背景Programmeddeathligand-1(PD-L1)expressionisnota
